Beijing ACCB Biotech Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 9

  • Investments
  • 1

Beijing ACCB Biotech General Information

Description

Developer of cancer detection and molecular diagnostic technologies created to provide advanced and reliable molecular diagnostic products for precision medicine. The company develops and commercializes in vitro diagnostic kits, clinical diagnostic tests for cancer screening, early-stage cancer detection, prognosis evaluation, precision cancer therapies and re-occurrence monitoring and polymerase chain reaction (PCR) kits to detect gene mutation, amplification, gene fusion, expression and polymorphisms, using in-house research laboratories and certified processes, enabling patients with individualized treatment plans.

Contact Information

Website
www.accb.com.cn
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 1555 Office Building
  • Hotel Nikko New Century
  • Beijing, 100048
  • China
+86 010
Primary Industry
Diagnostic Equipment
Other Industries
Outcome Management (Healthcare)
Laboratory Services (Healthcare)
Monitoring Equipment
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • 1555 Office Building
  • Hotel Nikko New Century
  • Beijing, 100048
  • China
+86 010

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beijing ACCB Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Beijing ACCB Biotech‘s full profile, request access.

Request a free trial

Beijing ACCB Biotech Patents

Beijing ACCB Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180112271-A1 Kit for detecting pik3ca gene mutation Inactive 29-May-2014
EP-3150717-A1 Pik3ca gene mutation detection kit Inactive 29-May-2014
EP-3150717-A4 Pik3ca gene mutation detection kit Inactive 29-May-2014
US-20130217115-A1 Plasmid standard for use in quantitative assays using fluorescent quantitative pcr Inactive 18-Oct-2010
EP-2540838-A1 Kit for quantitative detection of braf mutation Inactive 24-Feb-2010 C12Q1/6886
To view Beijing ACCB Biotech’s complete patent history, request access »

Beijing ACCB Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Beijing ACCB Biotech‘s full profile, request access.

Request a free trial

Beijing ACCB Biotech Investments (1)

Beijing ACCB Biotech’s most recent deal was a Seed Round with Cordmagic. The deal was made on 21-Mar-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cordmagic 21-Mar-2019 Seed Round Personal Products
To view Beijing ACCB Biotech’s complete investments history, request access »

Beijing ACCB Biotech FAQs

  • When was Beijing ACCB Biotech founded?

    Beijing ACCB Biotech was founded in 2004.

  • Where is Beijing ACCB Biotech headquartered?

    Beijing ACCB Biotech is headquartered in Beijing, China.

  • What industry is Beijing ACCB Biotech in?

    Beijing ACCB Biotech’s primary industry is Diagnostic Equipment.

  • Is Beijing ACCB Biotech a private or public company?

    Beijing ACCB Biotech is a Private company.

  • What is Beijing ACCB Biotech’s current revenue?

    The current revenue for Beijing ACCB Biotech is .

  • Who are Beijing ACCB Biotech’s investors?

    PICC TusHoldings Fund, SummitView Capital, Tsinghua Holdings, and TusHoldings have invested in Beijing ACCB Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »